ask="4.37"
ask_size="5000"
average_daily_volume="564931"
bid="4.12"
bid_size="400"
book_value="2.30"
change="+0.02"
change_from_200_day_moving_average="-0.43"
change_from_50_day_moving_average="-0.52"
change_from_52_week_high="-2.63"
change_From_52_week_low="1.12"
change_in_percent="+0.48%"
close="4.22"
dividend_pay_date="12/30/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.68"
ebitda="-43.09M"
eps_estimate_current_year="-1.47"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.84"
ex_dividend_date="12/31/2013"
float_shares="40197000"
high="4.23"
high_52_weeks="6.85"
last_trade_date="1/18/2017"
last_trade_price="4.22"
last_trade_size="100"
last_trade_time="4:00pm"
low="4.09"
low_52_weeks="3.10"
market_capitalization="276.10M"
moving_average_200_day="4.65"
moving_average_50_day="4.74"
name="Aralez Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="9.83"
open="4.19"
pe_ratio="N/A"
peg_ratio="-0.10"
percent_change_from_200_day_moving_average="-9.23%"
percent_change_from_50_day_moving_average="-11.00%"
percent_change_from_52_week_high="-38.39%"
percent_change_from_52_week_low="+36.13%"
previous_close="4.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.82"
price_per_sales="6.83"
revenue="40.23M"
shares_outstanding="65427000"
short_ratio="6.21"
stock_exchange="NMS"
symbol="ARLZ"
volume="352912"
weeks_range_52="3.10 - 6.85"
